Future studies should employ long-term dynamic sampling with time-series scRNA-seq to monitor the expression patterns of EIF1 and RPS12. Additionally, spatial transcriptomics can be utilized to determine their specific distribution within tumor tissues, further elucidating their bridging roles between tumor stroma and immune cells and providing new evidence for their molecular functions. The gene discussed is RPS12; the disease is neoplasm.